Not exact matches
St. Jude is working to drive the
overall survival rate for childhood cancer to 90 percent, and we won't stop until no
child dies from cancer.
Removal of a fifth course of chemotherapy containing cytarabine resulted in worse
overall survival and disease - free
survival in pediatric patients with low - risk acute myeloid leukemia (AML), according to the results (abstract 10515) of a pooled analysis of two
Children's Oncology Group (COG) trials presented at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 2 — 6 in Chicago.
The
survival rates for these different types of cancers vary, but
overall, the majority of
children diagnosed with cancer are able to survive long - term, thanks to advances in treatments, including immune - based therapies, over the past several decades.